Eton Pharmaceuticals, Inc. (ETON) NASDAQ
29.08
+4.96(+20.56%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
29.08
+4.96(+20.56%)
Currency In USD
| Market Cap | 455.01M |
| Enterprise Value | 460.09M |
| P/E Ratio | -170.07 |
| PEG Ratio | 2.89 |
| Price/Sales Ratio | 9.92 |
| Price/Book Ratio | 29.92 |
| Enterprise/Revenue | 9.72 |
| Enterprise/EBITDA | 202.96 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.06 |
| Operating Margin | -0.01 |
| Return On Assets | -0.05 |
| Return On Equity | -0.19 |
| Revenue | 79.95M |
| Revenue/Share | 2.97 |
| Gross Profit | 42.74M |
| EBITDA | 4.12M |
| Net Income | -4.6M |
| Diluted EPS | -0.17 |
| Total Cash | 25.94M |
| Total Cash/Share | 0.96 |
| Total Debt | 9.25M |
| Total Debt/Equity | 0.35 |
| Current Ratio | 1.57 |
| Book Value Per Share | 0.97 |
| 52-Week Change | 71.36 |
| 52-Week High | 29.29 |
| 52-Week Low | 13.09 |
| Moving Average 50 Days | 21.8 |
| Moving Average 200 Days | 18.15 |
| Average Volume | 367,629 |
| Shares Outstanding | 27.28M |
| % Held by Institutions | 59.09 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |